eXoZymes Inc. filed a Form 8-K on November 19, 2026, disclosing the voting results from its 2026 Annual Meeting of Stockholders held on November 13, 2026.
Key Highlights
- Record date shares: 9,304,701 shares of Common Stock were outstanding as of September 15, 2026, each entitled to one vote.
- Quorum achieved: 6,393,039 votes were present in person or by proxy, representing 68.70% of shares entitled to vote.
- Six directors elected: Christopher A. Marlett, Anthony DiGiandomenico, James U. Bowie, James J. Lalonde, Lon E. Bell, and Edgardo Rayo were each elected to serve until the 2027 annual meeting.
- Auditor ratified: RBSM LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026, receiving 6,391,977 votes in favor.
- Broker non-votes: Proposal 1 (director elections) recorded 340,251 broker non-votes.
eXoZymes 2026 Stockholder Vote: Director Elections and Auditor Ratification
According to the filing, eXoZymes Inc. (NASDAQ:EXOZ) held its 2026 Annual Meeting of Stockholders on November 13, 2026. The company disclosed that two proposals were put to a shareholder vote: the election of six director nominees and the ratification of the independent registered public accounting firm for fiscal year 2026.
For Proposal 1, all six nominees were elected. Christopher A. Marlett received the highest vote in favor at 6,050,804 shares for, with 654 against and 1,330 abstaining. Anthony DiGiandomenico received 6,045,885 shares for, 6,627 against, and 276 abstaining. James U. Bowie received 6,048,086 shares for, 4,015 against, and 687 abstaining. James J. Lalonde received 6,050,082 shares for, 2,019 against, and 687 abstaining. Lon E. Bell received 6,049,992 shares for, 2,109 against, and 687 abstaining. Edgardo Rayo received 6,047,658 shares for, 4,553 against, and 577 abstaining. Each director was elected to serve until the 2027 annual meeting of shareholders and until their successors are duly elected and qualified, the filing stated.
For Proposal 2, the filing reported that shareholders ratified the appointment of RBSM LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026. That proposal received 6,391,977 votes in favor, 500 against, and 562 abstaining, with no broker non-votes reported for this proposal. The filing was signed by Fouad Nawaz, VP of Finance and Principal Financial and Accounting Officer, on November 19, 2026.
What Was Disclosed
eXoZymes Inc. reported the final vote tallies from its November 13, 2026 Annual Meeting, confirming the election of six directors and the ratification of RBSM LLP as auditor for the fiscal year ending December 31, 2026.




Please wait processing your request...